Prognostic Gene Signature for Squamous Cell Carcinoma with a Higher Risk for Treatment Failure and Accelerated MEK-ERK Pathway Activity.

HNSCC MEK inhibitors MEK-ERK signaling genetic and epigenetic alterations multi-omics analysis prognostic classifier squamous cell carcinoma

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
15 Oct 2021
Historique:
received: 30 08 2021
revised: 07 10 2021
accepted: 09 10 2021
entrez: 23 10 2021
pubmed: 24 10 2021
medline: 24 10 2021
Statut: epublish

Résumé

Squamous cell carcinoma (SCC) is the most prevalent histological type of human cancer, including head and neck squamous cell carcinoma (HNSCC). However, reliable prognostic gene signatures for SCC and underlying genetic and/or epigenetic principles are still unclear. We identified 37 prognostic candidate genes by best cutoff computation based on survival in a pan-SCC cohort (

Identifiants

pubmed: 34680330
pii: cancers13205182
doi: 10.3390/cancers13205182
pmc: PMC8534038
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Clin Cancer Res. 2010 Mar 1;16(5):1613-23
pubmed: 20179232
Nature. 2019 May;569(7757):503-508
pubmed: 31068700
Nucleic Acids Res. 2016 Jan 4;44(D1):D380-4
pubmed: 26590256
Oral Oncol. 2003 Oct;39(7):638-47
pubmed: 12907202
Nat Rev Cancer. 2003 Jan;3(1):11-22
pubmed: 12509763
Cancers (Basel). 2020 Aug 24;12(9):
pubmed: 32847023
Int J Cancer. 2015 Dec 15;137(12):2846-57
pubmed: 26095926
Cancers (Basel). 2021 Mar 08;13(5):
pubmed: 33800421
Curr Cancer Drug Targets. 2020;20(6):417-428
pubmed: 32329688
Oral Oncol. 2019 Sep;96:77-88
pubmed: 31422218
J Pathol. 2012 Jun;227(2):146-56
pubmed: 22362593
J Cell Biochem. 2019 Apr 11;:
pubmed: 30977220
Clin Cancer Res. 2000 Mar;6(3):1052-62
pubmed: 10741734
NPJ Genom Med. 2019 Feb 1;4:2
pubmed: 30729033
Ann Oncol. 2017 Dec 1;28(12):3028-3036
pubmed: 29045535
Nucleic Acids Res. 2012 May;40(10):4288-97
pubmed: 22287627
Nucleic Acids Res. 2015 Jan;43(Database issue):D146-52
pubmed: 25378301
J Cell Physiol. 2017 Dec;232(12):3702-3713
pubmed: 28160492
Cancer Res. 2017 Nov 1;77(21):e31-e34
pubmed: 29092934
Lancet. 2010 Feb 20;375(9715):673-85
pubmed: 20171403
Nat Commun. 2017 Nov 24;8(1):1772
pubmed: 29176703
Bioinformatics. 2010 Jun 15;26(12):1572-3
pubmed: 20427518
Mol Ther Nucleic Acids. 2018 Jun 1;11:292-299
pubmed: 29858064
Semin Oncol Nurs. 2014 May;30(2):109-16
pubmed: 24794084
Ann Transl Med. 2019 Nov;7(22):640
pubmed: 31930041
Clin Cancer Res. 2017 May 1;23(9):2186-2194
pubmed: 28151720
Clin Chest Med. 2011 Dec;32(4):669-92
pubmed: 22054879
Sci Rep. 2020 Apr 30;10(1):7315
pubmed: 32355273
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Oncotarget. 2017 Dec 27;9(7):7424-7441
pubmed: 29484121
Annu Rev Pathol. 2009;4:49-70
pubmed: 18729723
Int J Clin Exp Pathol. 2018 Sep 01;11(9):4605-4613
pubmed: 31949859
Life Sci Alliance. 2020 May 7;3(6):
pubmed: 32381551
Clin Cancer Res. 2019 Jun 15;25(12):3528-3537
pubmed: 30833271
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Oncotarget. 2017 Aug 2;8(50):87292-87306
pubmed: 29152081
Clin Cancer Res. 2013 Mar 1;19(5):1197-203
pubmed: 23319825
Cell Rep. 2018 Apr 3;23(1):194-212.e6
pubmed: 29617660
Int J Cancer. 2019 Dec 15;145(12):3299-3310
pubmed: 31135957
Clin Cancer Res. 2014 Jul 15;20(14):3775-86
pubmed: 24812410
Bioinformatics. 2012 Aug 1;28(15):2062-3
pubmed: 22718787
Medicine (Baltimore). 2021 Jan 22;100(3):e24274
pubmed: 33546049
Nucleic Acids Res. 2018 Jan 4;46(D1):D296-D302
pubmed: 29126174
CA Cancer J Clin. 2020 Mar;70(2):125-137
pubmed: 32031692
Lung Cancer. 2019 Jul;133:48-55
pubmed: 31200828
Clin Cancer Res. 2013 Sep 15;19(18):5170-81
pubmed: 23881922
Nat Genet. 2017 Feb;49(2):180-185
pubmed: 28067913
Int J Cancer. 2011 Feb 15;128(4):927-35
pubmed: 20473886
Cancer Cell. 2021 Mar 8;39(3):361-379.e16
pubmed: 33417831
Cancer Manag Res. 2019 Nov 13;11:9609-9620
pubmed: 32009816
Mol Cancer Ther. 2015 Dec;14(12):2773-81
pubmed: 26384399
Genome Med. 2020 Feb 17;12(1):15
pubmed: 32066500
Mol Cancer Res. 2019 Jun;17(6):1279-1293
pubmed: 30910837
Mol Cancer. 2017 Jan 23;16(1):18
pubmed: 28114937
Front Oncol. 2021 Jun 11;11:678966
pubmed: 34178665
Oncotarget. 2015 Apr 10;6(10):7741-57
pubmed: 25797258
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Clin Cancer Res. 2014 May 15;20(10):2516-22
pubmed: 24664307
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Mol Cancer. 2016 Feb 20;15:16
pubmed: 26897742
Nature. 2019 Sep;573(7773):281-286
pubmed: 31485078
Matrix Biol. 2017 Jul;60-61:157-175
pubmed: 28109697
Oncoimmunology. 2018 Sep 21;8(1):e1515057
pubmed: 30546955
Int J Clin Exp Pathol. 2018 Feb 01;11(2):650-663
pubmed: 31938151
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Cancer Res. 2012 May 15;72(10):2457-67
pubmed: 22589270
Int J Mol Med. 2018 Apr;41(4):2070-2078
pubmed: 29393370
Cancer Metastasis Rev. 2010 Mar;29(1):5-14
pubmed: 20112052
Clin Cancer Res. 2020 Jul 15;26(14):3616-3628
pubmed: 32161122
Cells. 2019 Sep 20;8(10):
pubmed: 31547193
Sci Rep. 2019 Oct 10;9(1):14624
pubmed: 31601833
BMC Bioinformatics. 2013 Jan 16;14:7
pubmed: 23323831
Med Oncol. 2015 Feb;32(2):480
pubmed: 25575439
J Biol Chem. 1997 Jan 17;272(3):1677-81
pubmed: 8999845
Cell. 2017 Dec 14;171(7):1611-1624.e24
pubmed: 29198524
Biochem Biophys Res Commun. 2016 Jul 15;476(1):35-41
pubmed: 27207836
Cancer Cell. 2016 May 9;29(5):622-637
pubmed: 27165741
Cell. 2018 Apr 5;173(2):291-304.e6
pubmed: 29625048
Elife. 2018 Sep 04;7:
pubmed: 30178746
BMC Genomics. 2018 May 18;19(1):369
pubmed: 29776329
J Laryngol Otol. 2012 Nov;126(11):1134-7
pubmed: 22963824
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Int J Dermatol. 2015 Feb;54(2):130-40
pubmed: 25428226
Oral Dis. 2020 Apr 11;:
pubmed: 32277532
Int J Cancer. 2008 Sep 15;123(6):1422-8
pubmed: 18546259
Sci Rep. 2016 Jun 24;6:28294
pubmed: 27339696
Nat Commun. 2013;4:2612
pubmed: 24113773
Sci Rep. 2017 Dec 6;7(1):17064
pubmed: 29213088
Mol Cancer Ther. 2018 Jul;17(7):1585-1594
pubmed: 29636367
Cancers (Basel). 2021 Mar 17;13(6):
pubmed: 33802704
Stat Med. 1997 Feb 28;16(4):385-95
pubmed: 9044528
J Transl Med. 2019 Dec 17;17(1):423
pubmed: 31847905
Drugs. 2013 Jul;73(11):1245-54
pubmed: 23846731
Oncotarget. 2017 Jun 20;8(25):41364-41378
pubmed: 28489600
Biomed Res Int. 2019 Aug 7;2019:7376034
pubmed: 31485443
Mol Oncol. 2015 May;9(5):951-9
pubmed: 25888066
Cancer Res. 2013 Oct 15;73(20):6099-105
pubmed: 24097826
Genome Biol. 2019 Jan 22;20(1):18
pubmed: 30670076
Cell. 2016 Jul 28;166(3):740-754
pubmed: 27397505
Elife. 2015 Aug 12;4:
pubmed: 26267216

Auteurs

Bohai Feng (B)

Department of Otorhinolaryngology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310000, China.
Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, 69120 Heidelberg, Germany.

Kai Wang (K)

Department of Respiratory Medicine, Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu 322000, China.

Esther Herpel (E)

Institute of Pathology, University Hospital Heidelberg, and NCT Tissue Bank, National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.

Michaela Plath (M)

Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, 69120 Heidelberg, Germany.

Wilko Weichert (W)

Institute of Pathology, Technical University Munich (TUM), and German Cancer Consortium (DKTK) Partner Site, 80333 Munich, Germany.

Kolja Freier (K)

Department of Oral and Maxillofacial Surgery, Saarland University Hospital, 66421 Homburg, Germany.

Karim Zaoui (K)

Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, 69120 Heidelberg, Germany.

Jochen Hess (J)

Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Molecular Mechanisms of Head and Neck Tumors, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Classifications MeSH